CB1 Capital

Investor type

VC

Founded

2017

AUM

-

Location

Port Washington, New York, United States

Investment Ticket

$1-5 m

Investment Stage

Series B

Region of investment

North America
Investor profile last updated: 18 August, 2026

Profile

CB1 Capital is an investment manager and advisor that specializes in the supply chain of cannabinoid-based wellness solutions, products and therapies that address a wide range of unmet medical conditions, or have commercial use-cases. We are building a community of thought-leaders to help solve one of the most amazing riddles in modern medical history: how to unlock the universe of cannabinoid wellness properties from the cannabis plant.

Industry

Biotechnology Consumer Products Food and Beverage Cannabis Foodtech Healthcare Services Medical Devices Pharmaceuticals MedTech Life Sciences Infrastructure HealthTech

Contacts

Name
Title
Email
avatar
Ryan Norton Research Analyst
Research Analyst
-
avatar
John Clair Investor Relations & Business Development
Investor Relations & Business Development
-
Upgrade to see contacts
avatar
6XjsQom9JDdYgfK2 6XjsQom9JDdYgfK2
6XjsQom9JDdYgfK2
avatar
6XjsQom9JDdYgfK2 6XjsQom9JDdYgfK2
6XjsQom9JDdYgfK2
avatar
6XjsQom9JDdYgfK2 6XjsQom9JDdYgfK2
6XjsQom9JDdYgfK2
Investment-team contacts for CB1 Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about CB1 Capital

CB1 Capital is a venture capital firm. It backs companies at Series B, writing tickets of $1-5 m.
CB1 Capital is located in Port Washington, New York, United States.
CB1 Capital was founded in 2017.
CB1 Capital invests in companies and startups in Biotechnology, Consumer Products, Food and Beverage, Cannabis, Foodtech, Healthcare Services, Medical Devices, Pharmaceuticals, MedTech, Life Sciences, Infrastructure, HealthTech.
CB1 Capital invests in companies and startups in North America.
CB1 Capital invests in companies and startups at Series B.
CB1 Capital usually invests $1-5 m on average.
CB1 Capital can be reached through its website cb1cap.com and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for CB1 Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query CB1 Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 18 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.